WASHINGTON (AP) -- Dermatologists will soon get some high-tech help deciding which suspicious-looking moles should be removed and checked for melanoma, the deadliest form of skin cancer.
The Food and Drug Administration on Wednesday approved a device, called MelaFind, that makes detailed images of skin growths and uses a computer to analyze them for signs of cancer, offering a sort of second opinion to doctors.
The hope is to find more melanomas sooner. Nearly all patients diagnosed with early-stage melanoma can be treated and cured, but 85 percent of patients with late-stage melanoma die from it within five years.
The device's handheld attachment compares images to a database of 10,000 archived images and recommends whether a biopsy should be done.
The device is made by Mela Sciences Inc. of Irvington, N.Y.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.